Join Jonathan Feist and Joe Hindy as they welcome David Imel from VR Source to another great episode of the Android Authority Podcast. Joe goes out of his way to remind us that Lithium is a highly combustible substance, Launchers are adding Nougat features from the new Pixel Launcher, Sailfish and Marlin are getting ever closer to launch, there may be a new 7-inch Nexus/Pixel tablet coming and Pokemon Go updates to block root users - all root users, whether good or cheaters, say goodbye to GPS spoofing your in-game activity. Thank you for joining us. If you have not already, be sure to subscribe to the channel on your favorite podcast app, and subscribe to our YouTube channel. Also check out our partner sites - SoundGuys cover the best mobile audio gear and VR Source is the home of all our virtual reality coverage, from gear to games, check out VR Source for all kinds of reality. Finally, we are very happy to announce the official launch of TabTimes 2.0. We're still covering the same great tablet news and reviews, but you can look forward to expanded coverage on ultrabooks, smartphones and all the tech that helps you get through your day. Check out the new and improved TabTimes! Sign up for our various newsletters and enter for your chance to win one of our many giveaways. The Android Authority Podcast - discussing topics in Android every week.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
#2426 - Cameron Hanes & Adam Greentree
16 Dec 2025
The Joe Rogan Experience
#2425 - Ethan Hawke
11 Dec 2025
The Joe Rogan Experience
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare